Obesity and severe obesity in childhood and adolescence have been added to the list of conditions that put children and teens at increased risk for premature heart disease. The changed was noted in a new scientific statement from the American Heart Association published in the association’s journal Circulation.

Canon Medical Systems recently introduced AiCE (Advanced intelligent Clear IQ Engine), a deep convolutional neural network (DCNN) image reconstruction technology for computed tomography (CT). AiCE uses deep learning technology to differentiate signal from noise so that it removes noise while it preserves true signal.

Ra Medical Systems Inc. announced a 98 percent success rate in the results from a 52-patient study using the company’s DABRA System for the treatment of above- and below-the-knee peripheral artery disease (PAD). The data was presented by Ashok Kondur, M.D., FACC, FSCAI at the 2019 Leipzig Interventional Course (LINC) in Leipzig, Germany.

GE Healthcare announced Feb. 25 the sale of its biopharmaceutical business to Danaher, and GE Chairman and CEO Larry Culp Jr. said the deal signified that a planned 2019 initial public offering (IPO) for GE Healthcare is now unlikely. GE is reportedly weighing its options following the deal, which casts off the biopharmaceutical business for $21.4 billion.

Philips will unveil a new mixed reality concept developed together with Microsoft that the company says is designed for the operating room of the future. Based on Philips’ Azurion image-guided therapy platform and Microsoft’s HoloLens 2 holographic computing platform, the companies will showcase novel augmented reality applications for image-guided minimally invasive therapies. The technology will debut at Mobile World Congress (MWC) Barcelona, Feb. 25-28 in Barcelona, Spain.

Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The device was approved to facilitate, guide and support a guidewire while accessing the coronary system, the exchange of guidewires, and injection of radiopaque contrast media or saline solutions.